Vivacelle Bio Announces Submission of an IND Application with U.S. FDA for VBI-S, an Injectable Fluid for the Treatment of Patients with Severe Septic Shock

38

CHICAGO–(BUSINESS WIRE)–Vivacelle Bio is developing an injectable fluid for the treatment of shock due to sepsis that is superior to current products….

 

 

http://www.businesswire.com/news/home/20190606005501/en/Vivacelle-Bio-Announces-Submission-IND-Application-U.S./